ReviewFrontiers in oncology2025

Evaluating the combined efficacy of Telisotuzumab Vedotin and artificial intelligence in the treatment of non-squamous non-small cell lung cancer: a narrative review focusing on pharmaceutical and technical insights.

Syeda Huda Fatima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.